Interview 16 May 2019 Taking a Drug to Market “Is a Marathon, Not a Sprint” Based in Zurich, Molecular Partners is developing a new class of drugs that can address the complexity of cancer. At Labiotech Refresh in Zurich, CEO Patrick Amstutz shared what he’s learned on the journey to take the company where it is today. After completing a PhD at ETH Zurich, Amstutz founded Molecular Partners with a […] May 16, 2019 - 4 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
More News! 16 May 2019 Israeli Startup Raises €11M to Become the First to Sell Lab-Grown Steaks Aleph Farms has closed a Series A round of €10.7M ($12M) to beef up its manufacturing and get its lab-grown steaks into the market within the next four years. Aleph Farms is the first company to have created a lab-grown beef steak, which was publicly tasted last December. With the money raised, the company aims […] May 16, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
More News! 16 May 2019 UK Scientists Open Bacterial Genome Up to Making Artificial Proteins A research group from the University of Cambridge has created bacteria with less complexity in their genome, which could free up DNA code for producing synthetic proteins never before seen in nature. There are lots of redundancies in the DNA code, meaning there is sometimes more than one DNA sequence that can result in the […] May 16, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Expert Advice 16 May 2019 Avoid These Pitfalls When Creating a Life Sciences White Paper If you are looking for a way to educate your readers on a specific topic while collecting valuable leads at the same time, a white paper might just be the way to go. With a typical length of at least six pages, white papers are long-form content pieces about specialized topics, such as individual markets […] May 16, 2019 - 12 minutesmins - By Larissa Warneck-Silvestrin Share WhatsApp Twitter Linkedin Email
News and Trends 15 May 2019 €25M European Loan to Fund Diagnostics Tackling Antibiotic Resistance The Finnish biotech Mobidiag has received a loan of €25M from the European Investment Bank to commercialize diagnostic technology aimed at reducing antibiotic resistance. When patients get a bacterial infection, clinicians have to wait several days for traditional diagnosis techniques to tell them what kind of bacteria is causing the infection. While they wait, the […] May 15, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
In Depth 15 May 2019 The Missing Piece in the Microbiome Field Over the last decade, the biotech industry has built a lot of hype around the emerging field of microbiome research. Its potential to treat all sorts of diseases has captured the imagination of scientists and the number of early-stage studies is growing massively day by day. These studies have found correlation between the human microbiome […] May 15, 2019 - 7 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
Sponsored 15 May 2019 6 Tips on How to Choose the Best Software Solution for Your Biopharma Partnering Biotechnology is booming. Everyone working in the life science industry knows it and the numbers say so too. By 2025, for instance, the global biotech market is estimated to reach $727Bn. But this fast-paced environment also comes with its pitfalls. The great increase in competition leaves many companies struggling to find the necessary funds, the […] May 15, 2019 - 9 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 14 May 2019 RNAi Therapy Smashes Solid Tumors in Preclinical Tests Developed by the UK biotech Celixir, a therapy based on silencing genes with RNA molecules in a process called RNAi has shrunk tumors by 50% in culture. Although there are lots of innovative cancer treatments in the market, such as CAR T-cell therapy for blood cancer, solid tumors remain difficult to tackle. For this reason, […] May 14, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 14 May 2019 First Potential Gene Therapy for Hemophilia B Restores Blood Clotting in Phase II A gene therapy developed by the Dutch biotech uniQure increased the activity of a blood clotting protein enough to stop bleeds in patients with the blood disorder hemophilia B. Hemophilia B is a rare genetic condition in which patients have a mutation in the blood clotting protein factor IX (FIX), reducing its activity below 6% […] May 14, 2019 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 13 May 2019 ‘Guided Missile’ Cancer Immunotherapy Boosted by €62M Funding The Swiss-Italian biotech company Philogen has raised a private round of €62M to fund the phase III development of cancer immunotherapies that deliver immune cell-stimulating molecules directly to the tumor site. The money will push Philogen’s two lead cancer programs, currently in phase III, to the market. The funds will also help to expand the […] May 13, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Interview 13 May 2019 Putting DNA Repair on the Map Niall Martin is on a mission to put DNA repair on the map. He has already gone pretty far along the way to doing this, as the leader of the team that developed the blockbuster cancer drug Lynparza. He is now seeking to repeat this early success at Artios, where he is CEO. Martin talked […] May 13, 2019 - 8 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
News and Trends 13 May 2019 Cell Encapsulation Biotech Raises €7M to Target Cell Therapy Bottlenecks The French company Treefrog Therapeutics has raised over €7M in Series A investment to develop its encapsulation technology to improve the production of stem cells for cell therapies. Part of the Series A money will help Treefrog to automate its stem cell production process by 2021. The round will also fund the development of a […] May 13, 2019 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email